CompletedNCT00873249
Daily text reminders and antipsychotic medication adherence in schizophrenia
About this title
Read the official source — NCT00873249Observational studyAges 18+Spain
Understand this study
Who was this study for?
This study was for people with schizophrenia. Listed age limits: from 18 years. Other eligibility criteria applied.
- Listed locations
- Alicante and 24 more locationsSee all locations and recruitment
Study information
Study start dateApril 2009
- Recruitment status
- Completed
- Enrollment listed in the registry
- 339
- Sponsor
- AstraZeneca
- Sponsor type
- Unknown or unclear
- Study type
- Observational
- Intervention type
- Interview / survey / observational
- Locations
- Spain
- Age range
- Over 18 Years
- Official registry ID
- NCT00873249
- Official title
Show the full official title
Effect of Daily SMS Reminders on Medication Adherence to Oral Antipsychotics in Patients With Schizophrenia
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Alicante · Almería · Barcelona
22 more locations
- Berga
- Sabadell
- Burgos
- Santander
- Córdoba
- Granada
- León
- Lleida
- Madrid
- Málaga
- Murcia
- Pamplona
- Oviedo
- Palma Mallorca
- Salamanca
- Seville
- Tarragona
- Toledo
- Valencia
- Valladolid
- Zamora
- Calatayud
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is AstraZeneca.
Who was this study for?
This study was for people with schizophrenia. Listed age limits: from 18 years. Other eligibility criteria applied.
